Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older
PHASE3
This clinical research study will evaluate the safety and effectiveness of ...
Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis
PHASE3
This is an open-label, randomized, multicenter, 2-way crossover study in su...
Status
Completed
Location
Allergy and Asthma Associates of Southern California
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
PHASE3
This is a 6-month multi-center, randomized, double-blind, placebo-controlle...